Stockwinners Market Radar for August 18, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:34 EDT Cathie Wood's ARK Investment bought 496K shares of Invitae today

20:30 EDT Bitcoin falls to one-week low below $23,000 - Publicly traded companies in the crypto space include Bit Digital (BTBT), Coinbase (COIN), Core Scientific (CORZ), Greenidge Generation (GREE), Marathon Digital (MARA), MicroStrategy (MSTR), Riot Blockchain (RIOT), Stronghold Digital Mining (SDIG) and TeraWulf (WULF).

19:15 EDT Marpai director buys $138K in common stock - In a regulatory filing, Marpai disclosed that its director Yaron Eitan bought 175K shares of common stock on August 18th in a total transaction size of $138.3K.

18:44 EDT Agios Pharmaceuticals' Pyrukynd shows efficacy in pyruvate kinase deficiency - Agios Pharmaceuticals announced that data from the core period of the pivotal Phase 3 ACTIVATE-T study of Pyrukynd - mitapivat - in adults with pyruvate kinase - PK - deficiency who receive regular transfusions were published on August 18 in The Lancet Haematology. Pyrukynd is a first-in-class, oral PK activator and the first and only approved disease-modifying treatment for this rare, debilitating, lifelong hemolytic anemia. "The results of the ACTIVATE-T study confirm that treatment with mitapivat substantially reduced the need for transfusions in PK deficiency patients who regularly receive them," said Andreas Glenthoj, investigator in the Phase 3 study. The ACTIVATE-T study met its primary endpoint, with 10 of 27 patients receiving Pyrukynd achieving a transfusion reduction response compared with individual historical transfusion burden. Nine of these responders achieved a greater than or equal to 50% reduction. The safety profile of mitapivat was consistent with previously reported data. No serious adverse events were considered by the investigator to be related to study treatment, and only one patient experienced an adverse event leading to dose reduction. Pyrukynd was approved in February by the FDA for the treatment of hemolytic anemia in adults with PK deficiency and is also under review by the EMA as a potential treatment for adults with PK deficiency, and Agios expects a regulatory decision in the EU by the end of 2022. Both the FDA and EMA have granted orphan drug designation to Pyrukynd in PK deficiency.

18:28 EDT Vista Outdoor awarded $114.8M U.S. Army contract - Vista Outdoor Sales was awarded a $114,813,500 firm-fixed-price contract for the 5.56 mm Semi-Jacketed Frangible Cartridge, MK311 MOD 3 ammunition. Work locations and funding will be determined with each order, with an estimated completion date of Aug. 17, 2027.

18:08 EDT Cboe Global Markets increases quarterly dividend 4% to 50c per share - Cboe Global Markets has declared an increased quarterly cash dividend of 50c per share of common stock for Q3, representing a 4% increase from the prior quarter's dividend of 48c per share. The Q3 dividend is payable on September 15 to stockholders of record as of August 31.

17:49 EDT Kodiak Sciences announces upcoming presentations of Tarcocimab Tedromer data - Kodiak Sciences "announced that results from the Phase 3 BEACON study in Retinal Vein Occlusion of its investigational therapy tarcocimab tedromer will be presented at two upcoming ophthalmology conferences: the 22nd EURETINA Congress in Hamburg, Germany, and the 2022 American Academy of Ophthalmology Meeting in Chicago, Illinois."

17:24 EDT MSG Entertainment board authorizes management to explore potential spin-off - Madison Square Garden Entertainment announced that its board of directors has authorized the Company's management to explore a potential spin-off that would create a separately-traded public company comprised of its traditional live entertainment business - which includes a diverse collection of performance venues, entertainment and sports bookings and the Christmas Spectacular production - and the MSG Networks business. The proposed spin-off would separate these businesses from the Company's MSG Sphere and Tao Group Hospitality businesses. The potential transaction would provide shareholders with greater investment choice and visibility into each company's businesses and growth prospects, while enabling both companies to pursue distinct business and capital allocation strategies. If the Company proceeds with the separation, it would be structured as a tax-free spin-off to all MSGE shareholders. In the first step of the transaction, record holders of MSGE Class A and Class B common stock would receive a pro-rata distribution expected to be equivalent, in aggregate, to an approximately two-thirds economic interest in the live entertainment and media company. The remaining approximately one-third economic interest in the live entertainment and media company would be retained by MSG Entertainment. Reference Link

17:14 EDT Starbucks confirms COO John Culver to step down - In a regulatory 8-K filing, Starbucks states: "In connection with a redesign of the organizational structure at Starbucks Corporation, the chief operating officer role is being eliminated, effective as of October 1, 2022, and John Culver will be departing from the role of group president, North America and chief operating officer on such date. Mr. Culver will serve in an advisory capacity to Starbucks through January 1, 2023."

17:05 EDT Allstate names Jess Merten as CFO, succeeding Mario Rizzo - The company states: "Glenn Shapiro, who has successfully led the Property-Liability businesses since 2018, has decided to retire, having led the initiation of Transformative Growth and rapidly adapted to the impacts of inflation on auto insurance margins. Mario Rizzo, currently the Chief Financial Officer, has been a full partner in these successes and will succeed Glenn as President, Property-Liability. Jess Merten will assume the Chief Financial Officer role, leveraging his broad financial and operating experience at Allstate over the last decade."

17:02 EDT Krystal Biotech's BLA for dystrophic epidermolysis bullosa accepted by FDA - Krystal Biotech announced that the FDA has accepted for filing the company's Biologics License Application - BLA - for B-VEC for the treatment of patients with dystrophic epidermolysis bullosa. The application has been granted Priority Review designation, and the Prescription Drug User Fee Act action date is February 17, 2023. The FDA stated that it is not currently planning to hold an advisory committee meeting to discuss the application. B-VEC was previously granted Fast Track designation and Regenerative Medicine Advanced Therapy by the FDA for the treatment of DEB. The company plans to submit a marketing authorization application to the EMA in the second half of 2022.

17:01 EDT Home Depot announces new $15B share repurchase program - The board of directors authorized a new $15B share repurchase program, replacing its previous authorization.

16:39 EDT Google makes updates to Search to deal with clickbait and improve relevancy - Google is making updates to Search to address clickbait and improve the relevancy of search results. Danny Sullivan Public Liaison for Search, blogged in part earlier: "The company said Many of us have experienced the frustration of visiting a web page that seems like it has what we're looking for, but doesn't live up to our expectations. The content might not have the insights you want, or it may not even seem like it was created for, or even by, a person...Next week, we'll launch the "helpful content update" to tackle content that seems to have been primarily created for ranking well in search engines rather than to help or inform people...We know product reviews can play an important role in helping you make a decision on something to buy. Last year, we kicked off a series of updates to show more helpful, in-depth reviews based on first-hand expertise in search results." Reference Link

16:33 EDT MSG Entertainment board approves exploration of potential spin-off - Madison Square Garden Entertainment Corp. announced that its board has authorized the company's management to explore a potential spin-off that would create a separately-traded public company comprised of its traditional live entertainment business - which includes a diverse collection of performance venues, entertainment and sports bookings and the Christmas Spectacular production - and the MSG Networks business. The proposed spin-off would separate these businesses from the Company's MSG Sphere and Tao Group Hospitality businesses. The potential transaction would provide shareholders with greater investment choice and visibility into each company's businesses and growth prospects, while enabling both companies to pursue distinct business and capital allocation strategies. If the company proceeds with the separation, it would be structured as a tax-free spin-off to all MSGE shareholders. In the first step of the transaction, record holders of MSGE Class A and Class B common stock would receive a pro-rata distribution expected to be equivalent, in aggregate, to an approximately two-thirds economic interest in the live entertainment and media company. The remaining approximately one-third economic interest in the live entertainment and media company would be retained by MSG Entertainment. Those retained shares would then be available 1) for use in a tax-free exchange offer for the common stock of MSG Entertainment, 2) to raise capital for general corporate purposes, and/or 3) for use in a follow-on pro-rata spin-off to MSGE shareholders.

16:28 EDT Bed Bath & Beyond drops 20% to $14.60 after RC Ventures exits stake

16:19 EDT AMC CEO says Q3 film slate 'relatively weak,' 'quite optimistic' about Q4 demand - AMC (AMC) Chairman and CEO Adam Aron said, "Yesterday Cineworld (CNNWF), which is the world's second-largest movie theater circuit, issued a public statement that it anticipates low levels of admissions until November 2022, which are expected to negatively impact its liquidity position in the near-term." Aron continued, "At AMC, as we have publicly disclosed previously, the film slate in the third quarter of 2022 is expected to be relatively weak. However, we continue to be quite optimistic about the increasing demand for our portfolio of movie theatres in the fourth quarter of 2022 and calendar year 2023." Aron added, "As for AMC's liquidity, AMC ended the second quarter of 2022 with more than $1 billion of liquidity, thanks to significant amounts of cash raised in calendar years 2020 and 2021. Our new AMC Preferred Equity security, which begins trading on the New York Stock Exchange on Monday August 22, 2022, should also make us a much stronger company." Aron concluded, "Accordingly, we remain confident about AMC's future."

16:17 EDT Bridgewater Bancshares board approves up to $25M share buyback - Bridgewater Bancshares announced that its Board of Directors approved a new stock repurchase program authorizing the repurchase of up to $25M of its common stock. The 2022 Stock Repurchase Program replaces and supersedes the existing $40M stock repurchase program originally announced in January 2019, under which approximately $1.6M of Bridgewater's common stock remained authorized for repurchase as of August 17, 2022. Bridgewater repurchased approximately $1.6M of common stock from the 2019 Stock Repurchase Program during the third quarter of 2022. The 2019 Stock Repurchase Program was originally scheduled to expire in October 2022.

16:16 EDT Argan CEO Bosselmann retires, Watson named next CEO - Argan announced that Rainer H. Bosselmann, Founder, Chairman and Chief Executive Officer retired effective August 16, 2022. The Board of Directors of Argan has appointed David H. Watson to succeed Bosselmann as President and Chief Executive Officer and Watson will also join the Board. "On behalf of the Board, the management team, and Argan's employees, we want to thank Rainer for his leadership and significant, positive impact over almost two decades with the organization," said James Quinn, Argan's lead independent board member. "A steadfast and conservative leader, Rainer founded Argan in 2003 and fostered the management team that is in place today. During his tenure, he played a significant role in transforming the Company from a small, $30 million company to an international business with annual revenues and a market cap that exceed $500 million today. He built up the balance sheet, focused on margins, empowered employees throughout the organization and returned to shareholders approximately $175 million in dividends and $75 million in share repurchases. In addition, Rainer was instrumental in the evolution of Argan with the transformative acquisition of Gemma Power Systems in 2006. The Board is sincerely grateful to Rainer for his dedication to Argan and positive impact on shareholder value. We are all thankful that he has agreed to continue serving as a member of the Board."

16:10 EDT Bill.com names Sofya Pogreb COO - Bill.com announced that Irana Wasti has joined the company as Chief Product Officer and Sofya Pogreb has joined as Chief Operating Officer. Both executives will be reporting directly to CEO and Founder, Rene Lacerte. "We are thrilled to have Irana and Sofya join the team. Their experience building product and operational capabilities that support SMBs globally is invaluable," said Rene Lacerte, CEO and Founder of Bill.com. "We look forward to both of their contributions as we continue to build a company that is automating the future of finance so that businesses can flourish."

16:07 EDT Aeglea BioTherapeutics: MAA for pegzilarginase validated by EMA - Aeglea BioTherapeutics announced that a Marketing Authorization Application for pegzilarginase for the treatment of Arginase 1 Deficiency has been submitted to and successfully validated by the European Medicines Agency. The MAA was submitted by Immedica Pharma AB, Aeglea's commercialization partner in Europe and the Middle East. Pegzilarginase is a novel, recombinant human arginase 1 enzyme that in clinical trials has been shown to normalize the elevated levels of the amino acid arginine in patients with ARG1-D, a rare, progressive disease characterized by high levels of arginine. People living with ARG1-D experience severe spasticity-related mobility limitations, seizures, developmental delay, intellectual disability, and early mortality.

16:06 EDT Home Depot names Ted Decker Chair of the Board - The Home Depot announced that its Board of Directors has elected CEO and President Edward "Ted" Decker as chair of the board, effective Oct. 1. He will succeed Craig Menear, who will retire as chair effective Sept. 30. Decker, a 22-year veteran of The Home Depot, was named CEO in March. He was named president and COO in October 2020. Decker joined The Home Depot in 2000 as a director of business valuation and has held numerous strategic positions across the company

16:04 EDT Galapagos receives transparency notification from FMR - Pursuant to Belgian transparency legislation , Galapagos received a transparency notification on 15 August from FMR , who notified that it holds 3,740,842 of Galapagos' voting rights, consisting of 3,740,842 ordinary shares. FMR controls investment funds FIAM Holdings , Fidelity Management & Research Company , Fidelity Management Trust Company and Strategic Advisers of which Fidelity Management & Research Company increased its position to 3,303,128 voting rights, and no longer holds any equivalent financial instruments, and Strategic Advisers decreased its position to 10,082 voting rights. FMR's holding of 3,740,842 Galapagos' voting rights represents 5.69% of Galapagos' currently outstanding 65,728,511 shares. FMR thus remains above the 5% threshold of Galapagos' voting rights considering the change in the nature of holdings.

16:00 EDT Grove Collaborative Holdings Inc trading resumes

15:37 EDT Bright Minds Biosciences comments on recent trading activity - Bright Minds Biosciences is issuing the following statement in response to a request by the Investment Industry Regulatory Organization of Canada to comment on recent trading activity of its stock. "The company is not aware of any material, undisclosed corporate developments and has no material change in its business or affairs that has not been publicly disclosed that would account for the recent increase in volume or price. In accordance with applicable disclosure requirements, the company will advise the market of material changes, if any when they occur."

14:54 EDT Bavarian Nordic expands monkeypox vaccine capacity with U.S. agreement - Bavarian Nordic (BVNRY) announced today that the company has entered into an agreement with Grand River Aseptic Manufacturing, a U.S. based contract manufacturer, for fill and finish of Jynneos smallpox/monkeypox vaccine. As announced on July 15, Bavarian Nordic received an additional order for 2.5M doses the vaccine from the U.S. Biomedical Advanced Research and Development Authority, a part of the Administration for Strategic Preparedness and Response, which will be filled at Grand River using bulk vaccine already manufactured and invoiced under previous contracts with BARDA. Combined with previous orders, BARDA has requested a total of 5.5M doses for delivery in 2022 and 2023. The tech transfer of the production process to Grand River has already been initiated. "The aim is to complete the tech transfer within three months - a process which could normally take up to nine months, thus enabling GRAM to start manufacturing later this year," Bavarian Nordic said in a statement. Chimerix (CMRX) and Siga Technologies (SIGA), other smallpox vaccine makers, are lower in afternoon trading. Reference Link

13:11 EDT MEGL Stock trading halted, volatility trading pause

12:43 EDT Franklin Resources CEO Johnson sells 55,201 common shares - In a regulatory filing, Franklin Resources president and CEO Jennifer Johnson disclosed the sale of 55,201 common shares of the company on August 16 at a price of $28.7533 per share.

12:10 EDT Moderna drops 5% after WSJ says U.S. planning to end COVID shot payment

12:02 EDT Valneva initiates rolling FDA submission of chikungunya vaccine - Valneva announces that it has initiated rolling submission of the Biologics License Application to the Food and Drug Administration seeking approval of the company's single-shot chikungunya vaccine candidate in persons aged 18 years and above. Valneva is currently targeting the end of 2022 for completion of the BLA submission. The rolling BLA submission is part of the accelerated approval pathway agreed upon with the FDA in 2020.

12:00 EDT Rite Aid falls -11.8% - Rite Aid is down -11.8%, or -$1.23 to $9.28.

12:00 EDT EnLink Midstream rises 13.0% - EnLink Midstream is up 13.0%, or $1.28 to $11.12.

12:00 EDT Cedar Realty Trust rises 206.6% - Cedar Realty Trust is up 206.6%, or $19.52 to $28.98.

11:44 EDT Embracer Group acquires 'Teardown' developer Tuxedo Labs - Embracer Group has acquired 100% of the shares of Swedish developer Tuxedo Labs. Tuxedo Labs is best known for creating the hit voxel-based destruction PC game "Teardown." Embracer adds Dennis Gustafsson, Tuxedo Labs' founder and CTO, who is a highly technical visionary with a specialty in physics, and his team of 5. "Tuxedo Labs has created revolutionary technology that opens up vast possibilities for emergent gameplay and user-created content. Their hit title Teardown has the potential to become the standard-bearing platform for physics simulation in games. Many of us at Saber and our subsidiary 3D Realms have worked with Dennis since the mid-2000's. We are super excited to welcome Dennis, their CEO Marcus Dawson, and the rest of the Tuxedo Labs team into the Embracer family," said Matthew Karch, CEO of Saber Interactive. The parties have agreed not to disclose specific terms due to commercial reasons. The purchase price contains an upfront part and a long-term potential earn-out. The terms and conditions for the acquisition are in line with previous Embracer transactions. Founder Dennis Gustafsson is committed to Tuxedo Labs and the company will focus on growing in Malmo, Sweden. Post transaction business will remain as usual, with the team focused on expanding "Teardown."

11:42 EDT Embracer Group to acquire Singtrix, terms not disclosed - Embrace Group, through its wholly owned subsidiary Freemode, has entered into an agreement to acquire Singtrix LLC from its founders. Singtrix is a creator of vocal processing effects technology for karaoke, gaming, and entertainment. "The Singtrix team is one of the most highly regarded innovators in music gaming, vocal processing, and entertainment. Their proven track record behind groundbreaking mass music franchises and inspiring singing experiences is without parallel and makes them a perfect fit for Freemode's plan to vastly expand its entertainment offerings", says Lee Guinchard, CEO of Freemode. The parties have agreed not to disclose specific terms due to commercial reasons. The terms and conditions for the acquisition are in line with previous Embracer transactions.

11:39 EDT Embracer Group announces formation of Embracer Freemode - Embracer Group announced the formation of Embracer Freemode, an operative group comprised of certain gaming and entertainment companies owned by Embracer. Freemode is led by CEO Lee Guinchard, a 30-year gaming veteran and entrepreneur. Freemode provides a global strategic, operational, and financial support ecosystem for its collective of small to mid-sized companies to achieve operational efficiency and effectively grow their businesses to fulfil their long-term goals. In addition, Freemode will expand its operating activities in the retro, classic, and heritage gaming category, as well as investing in iconic gaming & entertainment properties. The newly formed operative group focuses on 6 broad and diverse business market segments including: Retro/Classic/Heritage Gaming & Entertainment, Game Development & Production, Devices, Gear & Collectables, Community & Ecommerce, New Idea & Technology Incubation and Production Services.

11:23 EDT WWE to launch NXT Europe in 2023 - WWE announced that the NXT brand will grow internationally with the creation of an all-new NXT Europe, with the launch planned for 2023. "Following the success of our live events and talent identification efforts throughout all of Europe, we believe this is the perfect time to expand NXT beyond the UK," said Shawn Michaels, WWE Vice President of Talent Development Creative. Launched in 2016, NXT UK has received critical acclaim and developed WWE main roster talent such as Rhea Ripley, Doudrop, Gunther and Butch. NXT Europe will reimagine the brand and its talent pipeline with a Pan European focus.

11:07 EDT United Bancorp increases quarterly dividend payment to 15.75c per share - On August 17, 2022, the Board of Directors of United Bancorp declared a third quarter dividend payment of $0.1575 per share for shareholders of record on September 9, 2022 with a payment date of September 20, 2022. This payment is greater than the regular cash dividends paid in the first and second quarters of the current year, which were $0.1525 and $0.1550 respectively. With this third quarter dividend payment and year-to-date, UBCP has paid total cash dividends of $0.6150 which is an increase of $0.08, or 15.0%, over the amount paid during the same period the previous year. At the third quarter payment level, the regular cash dividend produces a forward yield of 3.84% based on UBCP's market value of $16.39 at the most recent quarter-end.

11:04 EDT Chicken Soup for the Soul Entertainment trading resumes

10:59 EDT Chicken Soup for the Soul Entertainment trading halted, volatility trading pause

10:28 EDT Tufin: Transaction with Turn/River Capital remains on track

10:17 EDT Massachusetts REIT signs contract for two Knightscope ASRs - Knightscope announced that a 60-year-old real estate development, investment and management firm with over 19,100 units under management in 19 U.S. states has signed a contract for Knightscope's K1 and K5 Autonomous Security Robots. This new client provides residents with high-quality housing in all asset classes, particularly communities with affordable housing components, like the property in Atlanta, Georgia, where these two ASRs will be utilized.

10:08 EDT Blue Water Vaccines Inc trading halted, volatility trading pause

10:01 EDT S&T Bancorp names Rachel Smydo as general counsel, succeeding George Basara - S&T Bancorp announced that Rachel Smydo will assume the role of general counsel on August 22. Smydo will succeed George Basara, current general counsel, who retires on August 31. Most recently, Smydo held the role of deputy general counsel at the Federal Home Loan Bank of Pittsburgh.

10:00 EDT Youdao falls -10.4% - Youdao is down -10.4%, or -58c to $5.00.

10:00 EDT SIGNA Sports United rises 16.5% - SIGNA Sports United is up 16.5%, or 83c to $5.91.

10:00 EDT Cedar Realty Trust rises 206.5% - Cedar Realty Trust is up 206.5%, or $19.51 to $28.96.

09:59 EDT Kohl's expects 'modest improvement' in 2H22 results vs. 1H22 - Seeing middle income customer pressured the most, with higher income customers spending more. Says attracting more high income shoppers. Expects "heightened" promotional environment in 2H22. Feels "very good" about health of credit customer. Says Sephora outperforming the chain, and it remains the company's "number one initiative."

09:47 EDT SQM falls -7.3% - SQM is down -7.3%, or -$7.60 to $96.82.

09:47 EDT Youdao falls -9.7% - Youdao is down -9.7%, or -54c to $5.04.

09:47 EDT Wolfspeed rises 28.2% - Wolfspeed is up 28.2%, or $24.15 to $109.80.

09:43 EDT WeTrade Group Inc trading resumes

09:38 EDT WeTrade Group Inc trading halted, volatility trading pause

09:36 EDT Creatd to increase ownership in Dune, WHE in all-stock transactios - Creatd revealed its plans to purchase additional shares in two of its subsidiary companies, Dune and WHE Agency. Following the close of the proposed transactions, the Company's ownership stake in Dune would increase to 70%, and its ownership stake in WHE would increase to 61%, thereby improving the Company's balance sheet, while at the same time helping to ready the Company to explore a variety of future financing opportunities, including the potential spin-off of certain Creatd assets. Under the terms of the Memorandum of Understanding signed with Dune, Creatd will purchase an additional 20% ownership stake in exchange for approximately $360,000 in Creatd common stock at a price of $1.32 per share, or approximately 270,000 shares. Under the terms of the MOU signed with WHE, the Company will purchase an additional 17% ownership stake in exchange for approximately the same purchase price.

09:26 EDT Kohl's expects year end inventory to end up 'high teens' - Expects $825M in CapEx in 2022. Expects balance sheet, cash flow to be "challenged" in 2022. Says exploring opportunities to monetize select real estate assets. Sees 2H22 gross margin similar to Q2 level.

09:21 EDT Kohl's reports Q2 gross margin 39.6% vs. 42.5% a year ago - Cites increased investment in growth initiatives, including Sephora.

09:18 EDT Kohl's says Q2 results reflect cost-conscious middle income customer - Says "aggressively clearing" excess inventory. Says making progress in strategic transformation. Remains "firmly committed" to health of balance sheet, dividend. Says digital sales accounted for 28% of net sales in Q2, up from 26% a year earlier. Has seen "significant shift" in consumer behavior over past few months and expects it to persist near term. Says "vast majority" of Sephora impact lies ahead. Says testing in-store pickup of Sephora orders. Says to date, back to school trends "in-line" with expectations. Says expanding outdoor brands to more stores in the fall. Comments taken from Q2 earnings conference call.

09:18 EDT Cassava: JPAD finds no evidence of data manipulation in simufilam publication - Cassava Sciences was recently informed by the Journal of Prevention of Alzheimer's Disease that there is no convincing evidence to support allegations of data manipulation in a 2020 paper on simufilam co-authored by the Company's personnel and its science collaborators. JPAD communicated the following statement to the Company on Monday, August 15th after the close of market, which is reprinted in full below: "We have completed our review of your article "PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients". We do not find convincing evidence of manipulation of data or intent to mislead, and therefore take no action regarding the published paper." "From the onset, I have said that allegations of research misconduct are false, and for good reason - I see no supporting evidence for the allegations," said Remi Barbier, President & CEO. "I'm hopeful that written pronouncements from neutral and independent science experts will help close the chapter of baseless attacks against our science. At some point it becomes irrational for our detractors to repeat over and over again the same old tired mantra of data manipulation." A related investigation by academic authorities at The City University of New York is ongoing. Pending a public response from CUNY, both Neurobiology of Aging and Journal of Neuroscience previously issued an outstanding "expression of concern", which is a non-standardized type of editorial notice used by academic publishers to raise awareness to a possible problem, according to the Council of Science Editors.

09:15 EDT ENG wins prime spot on $20M contract with USACE - ENG has been designated as one of three prime contractors by the US Army Corps of Engineers on a $20 million five-year contract to support and upgrade control system installations at hydroelectric facilities within the USACE's South Atlantic region. As per the terms of the contract, EGS will compete with the other two contractors for the award of task orders for such assignments as technology upgrades and refreshes of existing systems, new system designs and installations, and life cycle maintenance of new and existing systems.

09:13 EDT EnWave signsTELOA pact with Wyckoff Farms for drying of premium hops - EnWave announced that it has signed a Technology Evaluation and License Option Agreement with Wyckoff Farms to trial the use of a 10kW Radiant Energy Vacuum dehydration machine for the drying of premium hop products. The 10kW REV machinery will be installed at Wyckoff Farms' facility located in Grandview, Washington, USA. During the term of the TELOA, Wyckoff Farms will hold an exclusive option to license EnWave's technology for the drying of hop products in the United States of America. Wyckoff Farms is the parent company of MicroDried one of EnWave's longest standing licensed partners of REV drying technology. Since 2012, MicroDried has used REV drying to create 100% all-natural, high quality dried fruit and vegetables that are rich in nutritional values and health benefits. Over the past decade, Wyckoff Farms has solidified its commitment to REV technology by scaling up to three large-scale REV machines, all operating at MicroDried's processing facility in Nampa, Idaho.

09:08 EDT Trimble invests in agricultural technology company Sabanto - Trimble announced its investment in Sabanto. Sabanto is a U.S.-based agricultural technology company focusing on autonomous workflows throughout the farming cycle being offered as Farming as a Service. This investment supports Trimble's mission to invest in early and growth-stage companies that are accelerating innovation, digital transformation and sustainability in the industries Trimble serves-such as agriculture, construction, geospatial and transportation. The investment terms were not disclosed. Sabanto provides FaaS through swarms of multiple smaller tractors equipped with its autonomous technology to perform in-field operations.

09:05 EDT Valneva says DoD decided not to exercise second option year for Ixiaro - Valneva announced that the U.S. Department of Defense has decided not to exercise the second option year of the contract to supply Valneva's Japanese encephalitis vaccine Ixiaro. "Due to the past and ongoing impact of the COVID-19 pandemic on its operations, the DoD considers its existing Ixiaro supply levels sufficient to meet current needs. The DoD has communicated an interest in negotiating a new supply contract in 2023, once inventory returns to standard levels," the company said in a statement. Valneva expects no impact on its 2022 financial guidance as a result of this decision and will continue deliveries of Ixiaro pursuant to the terms of the first option year, which the DoD exercised with amended terms, through Q4 of 2022. The total minimum value of the existing supply contract was approximately $118M, assuming the exercise of the second option year, which had a minimum value of approximately $36M for 250,000 doses. Thomas Lingelbach, CEO of Valneva, commented: "We thank the DoD for their partnership and look forward to further contract negotiations in the future. In parallel, we continue to see significant recovery in the private travel market for Ixiaro, which more than tripled in the first half of this year compared to the first half of 2021."

09:03 EDT Borqs Technologies signs revised licensing deals with mobile chipset vendor - Borqs Technologies provides the following updates on the Company. The Company has signed a set of revised licensing agreements with a mobile chipset vendor, which includes purchasing the 5G patent licensing agreement and use of the latest mobile chipsets. Borqs' R&D team and sales team in India are working closely with partners and customers to build the 5G ecosystem in India, including the development of 5G phones, 5G gateways for residential and business premises, and other devices. Borqs has shipped more than 10 million wireless devices in India, including phones, tablets, wireless routers, and IoT products.

09:03 EDT Grubhub, Bank of America partner to offer Grubhub+ for free to cardholders - Grubhub and Bank of America (BAC) announced that eligible Bank of America cardholders can receive Grubhub+ free for one year, providing unlimited $0 delivery fees on orders of $12 or more and exclusive Perks from restaurants on Grubhub. Starting August 18, eligible cardholders can activate a one-year, complimentary Grubhub+ membership trial, valued at nearly $120. Grubhub+ members also enjoy a donation match on Grubhub+ orders when they are opted into Grubhub's Donate the Change program, which raised more than $25 million in 2021 alone, benefiting more than 20 charitable organizations. Grubhub is part of Just Eat Takeaway.com (JTKWY).

09:02 EDT Shineco appoints Aamir Ali Quraishi to board of directors - Shineco has appointed Mr. Aamir Ali Quraishi as a new Independent Director of the Board effective immediately, to succeed Mr. Yanzeng An. Mr. Quraishi was also appointed to the Company's Audit Committee as well as Chairman of the Company's Nominating Committee. Since April 2021, Mr. Quraishi has been serving as the Non-Executive Chairman of Bowen Fintech PLC,

08:59 EDT Newegg Commerce annouces exhibiting plans for CNE Gaming Garage - Newegg Commerce (NEGG) announced its exhibiting plans for the CNE Gaming Garage Powered by AMD (AMD). The CNE Gaming Garage is part of the Canadian National Exhibition, CNE, which takes place Aug. 19-Sept. 5 at the Exhibition Place in Toronto. Newegg will showcase a custom Advanced Battlestations PC in a glass display within the CNE Gaming Garage Powered by AMD throughout all 18 days of the exhibition. "CNE Gaming Garage is an exciting opportunity for Canadians who are passionate about gaming and technology to see and play new products," said Danny Yip, Senior Category Manager for Newegg Canada. "Our special gaming PC will be prominently displayed throughout CNE, and we're looking forward to seeing attendees' reactions. CNE Gaming Garage is an important opportunity for the industry, and Newegg is glad to take part during the 18 days."

08:53 EDT Pressure BioSciences announces contract with Canopy CBD Farms - Pressure BioSciences announced the execution of a manufacturing, sales, and distribution agreement with Canopy CBD Farms, CCF, with a strong focus in the Massachusetts/New England hemp-derived CBD market, has assembled an aggressive distribution plan that anticipates nano-CBD product sales of nearly $6 million over the first 12-months post-release. Under GAAP rules/standards, PBI believes it will capture approximately $2 million of CCF's expected product revenue.

08:42 EDT Mynaric appoints Mustafa Veziroglu as president - Mynaric named Mustafa Veziroglu as President of Mynaric and the newest member of its management board. In this role, Mustafa Veziroglu will oversee development, qualification and serial production of Mynaric's laser communications products that are in high demand by government and commercial customers. Prior to joining Mynaric, Mustafa Veziroglu served as the COO of SA Photonics. In his role, Mustafa Veziroglu will be responsible for all operational product-related activities within Mynaric overseeing the entire product lifecycle from development through delivery. He will be based in Munich, Germany.

08:39 EDT American Resources applauds Inflation Reduction Act - American Resources applauds the Inflation Reduction Act's support for a more resilient, domestic supply chain for critical minerals and highlights how the bill is highly aligned with its industry-leading accomplishments. Mark Jensen, CEO of American Resources commented, "We believe it is highly important for the United States to develop a resilient and sustainable supply chain of critical and rare earth elements to significantly reduce the dependency on foreign nations. Our monumental milestone of producing the ultra-high pure and separated rare earth magnet elements neodymium, praseodymium and dysprosium on a commercial scale using our next-generation chromatographic separation process technology is a massive leap forward for both our Company and our nation. This environmentally-safe, low-cost and flexible technology will redefine how critical raw materials are sourced and processed. Additionally, we applaud the federal government for the provisions within the Inflation Reduction Act that aim to support the transition towards a broader electrified economy, and at the same time supports U.S. manufacturing. While the critical mineral requirements within the bill credits are aggressive and stringent, we are confident our ReElement Technologies division is in a leading position to simultaneously help recipients achieve certain standards and support the buildout of our own critical and rare earth mineral processing facilities."

08:38 EDT Iteris selected by VDOT for connected, automated vehicle initiative - Iteris announced that it has been awarded a sub-contract by the Virginia Department of Transportation, VDOT, for connected and automated vehicle, CAV, related planning services, representing continued demand for Iteris' specialized consulting services in a key geographic market. The project supports VDOT's initiative to keep pace with advancements in CAV technologies. The goal is to ensure an efficient transition to future transportation systems management and operations. Under the terms of the sub-contract, Iteris will deliver a CAV data strategic plan to help VDOT gain a high-level understanding of how to integrate CAV data from external sources into VDOT's information technology and operations technology related systems. This will help enhance their business functions, and conversely, by sharing agency-wide business data from their IT- and OT-related systems, help serve CAV data needs and support deployment of CAV applications.

08:35 EDT Milestone Scientific commences CompuFlo Epidural disposables sales to UofL - Milestone Scientific reported that, following an evaluation, it has commenced sales of its CompuFlo Epidural disposables to UofL Health. UofL Health owns and operates six hospitals and four medical centers, providing patient care to more than 1.5 million patients each year in the state of Kentucky. UofL Health has begun implementing the CompuFlo Epidural System for obstetric anesthesia, acute pain, and chronic pain within its labor and delivery, operating room and pain clinic teams.

08:33 EDT FinWise Bancorp announces 644,241 share repurchase program - FinWise Bancorp announced that its Board of Directors has approved a share repurchase program that authorizes the Company to repurchase up to 5% of its total number of shares of outstanding common stock as of August 16, or 644,241 shares. The repurchases will be made at the Company's discretion through August 31, 2024. "We are pleased to announce that our Board has authorized a share repurchase program, as we are always committed to enhancing long-term shareholder value," said Kent Landvatter, Chief Executive Officer of FinWise. "Beyond returning capital to shareholders, we remain committed to opportunistically invest in our business to further differentiate our unique business model."

08:33 EDT KULR Technology secures second order from e-commerce, cloud computing customer - KULR Technology Group has received two orders from a leading Fortune 20 e-commerce and cloud computing company for its next generation Li-ion battery powered commercial drone delivery fleet.

08:25 EDT Kohl's cuts FY22 operating margin view to 4.2% -4.5% from 7%-7.2%

08:21 EDT Portage Biotech says CEO Dr. Ian Walters, appointed Chairman of Board - Portage Biotech announced that Dr. Ian Walters, Chief Executive Officer of Portage, will be appointed Chairman of Portage's Board of Directors. Dr. Greg Bailey, current Chairman, will transition to lead Director. Additionally, the company hired Justin Fairchild, MPH, as Vice President of Development. "The changes reflect the Board's confidence and acknowledgement of Portage's recent growth and progress under Dr. Walters' leadership," remarked Dr. Bailey. "Dr. Walters has decades of industry expertise, deep knowledge of immuno-oncology drug development and is dedicated to Portage's mission. Despite the challenging financial market conditions, he has been able to grow the team and pipeline and Portage is now poised to deliver multiple data readouts over the coming year."

08:18 EDT Pasithea Therapeutics present results of tolerizing vaccine program - Pasithea Therapeutics announced it will present the preclinical proof of concept study results of its tolerizing vaccine program in multiple sclerosis on August 30th at the international conference "From Laboratory to Clinic: Medicine after COVID" held at Trinity College, Oxford University, United Kingdom. From Laboratory to Clinic is an annual translational research conference established in 1984 that brings together basic scientists, clinicians, and industry researchers to explore how the latest discoveries in immunology and molecular medicine can be applied to improve clinical medicine. During the Symposium, Pasithea's Chairman, National Academy of Sciences Professor Lawrence Steinman, will be giving the opening keynote lecture. Other speakers will include Dr. Carola Vinuesa, Professor at the Francis Crick Institute in London; Dr. Gali Alter, Professor of medicine at Harvard Medical School; Dr. Jeffrey Ravetch, Professor and head of the Laboratory of Molecular Genetics and Immunology at the Rockefeller University and Dr. Anne Schaefer, Vice-chair of Neuroscience at the Icahn School of Medicine at Mount Sinai.

08:15 EDT Enphase Energy, Complete Solar expand solar, battery deployments across U.S. - Enphase Energy announced that Complete Sola is seeing increased deployments of Enphase Energy Systems powered by IQ8 Microinverters and IQ Batteries, as homeowners across the United States are hit with extreme weather and rising energy prices.Complete Solar has seen a significant increase in solar and battery installations for new residential customers over the past several years. Homeowners are seeking smart, reliable, and safer solutions, such as the Enphase IQ Microinverters and Batteries, for home energy systems to help keep the lights on. And with the revolutionary IQ8 Microinverter, the industry's first microgrid-forming microinverter launched late last year, the Enphase Energy System offers homeowners even greater resilience than ever before."At Complete Solar, we only partner with high-quality, solar technology providers to ensure the highest level of the customer experience," said Dave Anderson, co-founder and chief marketing officer at Complete Solar, an Enphase Gold level installer. "The Enphase Energy System is powered by the most innovative microinverter and battery technology, and we're proud to deliver this next-generation home energy solution to homeowners across the country, unlocking unmatched energy resilience, savings, and independence."

08:13 EDT Semtech's LoRa Devices integrated into IoT Ventures, Lacuna Space - Semtech Corporation announced a collaboration with New Zealand's IoT Ventures and global connectivity provider Lacuna Space. IoT Ventures has used Semtech's LoRa devices to develop its Drought Early Warning System, a network of low-cost rainwater tank and rain monitors to analyze water consumption and rain forecasts in remote New Zealand and South Pacific Island communities. The water monitoring system features ultra-low power, small form-factor sensors, which are solar powered and provide an in-field life of seven to 10 years without intervention, according to IoT Ventures. In addition, the Drought Early Warning System is starting to use Semtech's Long Range-Frequency Hopping Spread Spectrum satellite connectivity to seamlessly integrate with a terrestrial network using LoRaWAN, delivering a flexible solution for isolated locations, and can be deployed and managed by local citizens without requiring substantial internet service provider infrastructure. Matt Hector-Taylor, co-founder at IoT Ventures, said, "By combining low-cost sensors with LoRa and strong connectivity signal capabilities, the joint solution helps provide consistent access to clean drinking water for citizens of some of the most remote islands in the world, supports the United Nations Sustainability goals and reduces crisis response."

08:12 EDT 89bio completes enrollment in Phase 2b trial of pegozafermin for NASH treatment - 89bio announced that it has completed enrollment in ENLIVEN, the Phase 2b trial of pegozafermin for the treatment of NASH. "We are very pleased to have successfully completed enrollment of 219 total patients in ENLIVEN, a well-powered trial that builds on positive data demonstrating pegozafermin's broad metabolic effects and favorable safety/tolerability profile," said Hank Mansbach, Chief Medical Officer of 89bio. "The impressive pace of enrollment is a testament to both the high level of engagement by our clinical trial sites and our team's strategic execution and brings us one step closer to addressing the need for new treatment options for patients suffering from NASH. We see this as a significant milestone in the pegozafermin clinical program and, building on this momentum, we expect to report topline data from ENLIVEN in the first quarter of 2023."

08:11 EDT IonQ, Airbus sign agreement to collaborate of aircraft loading project - IonQ (IONQ) announced a collaboration with Airbus (EADSY) to explore the potential application and benefits of quantum computing for aerospace services and passenger experiences. The Quantum Aircraft Loading Optimization & Quantum Machine Learning project will be a 12-month project that culminates in the development of a prototype aircraft-loading quantum application, hands-on collaboration and coaching sessions for Airbus developers and engineers, and an exploration of future integrations of quantum computers for Airbus and its customers. Airbus' partnership with IonQ is the first step toward developing smarter algorithms based on quantum computers that can potentially lead to cost savings due to more optimized distribution of cargo on flights. Looking long-term, Airbus hopes to use quantum algorithms to improve other areas of air travel, including reduced fuel consumption, better aerodynamics, and optimized trajectories. "As the aerospace industry looks for new ways to navigate the continued impact of the pandemic and overcome supply chain hurdles, we're pleased to collaborate with Airbus and provide them with the quantum tools and expertise to develop improved aircraft-loading capabilities," said Peter Chapman, CEO and President, IonQ. "While it's still early days in our yearlong project, the potential for quantum to reshape how airplane manufacturers balance passenger experience with aircraft production and performance is what excites our team most for what's next in the aviation industry."

08:10 EDT Dynatrace appoints Fitzpatrick as General Counsel, Quackenbush as CPO - Software intelligence company Dynatrace (DT) announced the appointment of two new executives to its leadership team. As General Counsel, Nicole Fitzpatrick is accountable for all Dynatrace legal and regulatory affairs worldwide and will lead the company's global Environment, Social, and Governance program. As Chief People Officer, CPO, Sue Quackenbush is responsible for driving Dynatrace talent strategies and a workplace culture that continues to foster innovation, customer-centricity, and inclusiveness. Fitzpatrick brings more than 20 years of legal experience to Dynatrace. Before this role, she served as Chief ESG Officer and Deputy General Counsel at cloud computing leader Akamai Technologies (AKAM). Quackenbush brings more than 25 years of human resources experience to Dynatrace. Before this position, she served as Chief Human Resources Officer at cloud communications leader Vonage (VG).

08:09 EDT ViaSat joins Inteliwell well construction JV with Transocean, Intellilift - Viasat (VSAT) has agreed to join Inteliwell, a JV with Transocean (RIG) and Intelilift, a subsidiary of Nekkar ASA. Inteliwell's mission is to decrease drilling times through rig automation and streamlining of the well construction process using new processes and tools driven by artificial intelligence. Inteliwell will offer a suite of applications that will provide an end-to-end, closed-loop workflow for well construction planning, execution, and monitoring. For its part, INTELIE by Viasat, part of the company's 2021 RigNet acquisition, will provide operational AI expertise, real-time data analytics, and planning components to the Inteliwell JV. The offering will be comprised of three key applications: InteliPlan, InteliAutomate and InteliAssist, which will create digital well plans that interface with a drilling rig's control system to autonomously execute tasks, greatly expediting the well construction process.

08:08 EDT Tandem Diabetes achieves milestone of 1M insulin boluses delivered using app - Tandem Diabetes Care announced that t:slim X2 insulin pump users have delivered more than 1 million insulin boluses using the t:connect app feature on their personal mobile device in the first month following its commercial release. "The rapid adoption of our mobile bolus feature demonstrates the importance of our offering new technologies that provide lifestyle benefits, in addition to improved clinical outcomes, to people living with diabetes," said John Sheridan, President and CEO of Tandem Diabetes Care. "We are committed to leading in diabetes technology by continually enhancing the solutions we provide and offering best-in-class customer care."

08:06 EDT ABM to acquire RavenVolt for initial price of $170M - ABM announced it has entered into a definitive agreement to acquire RavenVolt, headquartered in Alpharetta, Georgia, in an all cash transaction. RavenVolt is a leading nationwide provider of advanced turn-key microgrid systems utilized by diversified commercial and industrial customers, national retailers, utilities, and municipalities. RavenVolt employs over 80 people and is projected to generate revenue of $70 million to $80 million and EBITDA of $17 million to $19 million in calendar 2022. The transaction is expected to close during ABM's fourth fiscal quarter of 2022, subject to the expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Act and other closing conditions. The acquisition of RavenVolt is reflective of ABM's ELEVATE strategy to grow via strategic acquisitions which expand the Company's core capabilities in attractive and dynamic end-markets, such as the rapidly growing and evolving microgrid market. Commercial customers are increasingly turning to microgrids as the solution of choice to bolster their on-site energy capacity, reduce emissions and meet sustainability goals, and ensure power resiliency during periods of primary power grid disruption. RavenVolt designs and installs customized microgrid solutions, including RavenVolt branded generators and switchgear that deliver modular and redundant power to ensure energy resiliency and reliability. The acquisition of RavenVolt is a natural extension of ABM's Technical Solutions service offerings and enhances ABM's position as a market leader in EV infrastructure, power and bundled energy solutions. The addition of RavenVolt's microgrid capabilities also offers ABM the potential to accelerate growth in its eMobility business through the delivery of customized power solutions in facilities where additional power generation capacity is needed to support EV charging. ABM will acquire RavenVolt for an initial purchase price of $170 million in cash at closing, plus the potential for post-closing earn-out consideration payable in cash in calendar years 2024, 2025, and 2026, if the RavenVolt business achieves certain financial metrics in calendar years 2023, 2024 and 2025. The maximum aggregate cash earn-out payment amount is $280 million, resulting in a maximum total purchase price of $450 million. To achieve the full earn-out of $280 million, RavenVolt would need to generate cumulative EBITDA of $150 million in calendar years 2023 through 2025.

08:06 EDT TowneBank to acquire Farmers Bankshares and Farmers Bank in accretive deal - Hampton Roads based TowneBank and Farmers Bankshares announced the signing of a definitive merger agreement pursuant to which Farmers Bankshares, Inc. and Farmers Bank, will merge with and into TowneBank. The proposed transaction will solidify TowneBank's number one market share in the Virginia Beach-Norfolk-Newport News MSA adding Isle of Wight and Southampton counties to the company's service area while expanding Towne Insurance revenues. Based on financials reported on June 30, the combined companies would have total assets of $17.5B, loans of $10.9B and deposits of $14.5B. Under the terms of the agreement, shareholders of Farmers will receive 0.6050 shares of TowneBank common stock for each share of Farmers owned. This implies a deal value per share of $17.82, or approximately $56M, based on TowneBank's 20-day average stock price of $29.46 ending Wednesday, August 17. TowneBank expects the merger to be approximately 5% accretive to earnings per share with fully phased-in cost savings on a GAAP basis. TowneBank anticipates the tangible book value dilution per common share impact to be less than 3% on a GAAP basis and accretive excluding accumulated other comprehensive income and interest rate marks impact.

08:04 EDT ATIF Holdings to provide IPO advisory services to Massimo Motor Sports - ATIF Holdings is pleased to announce that it has signed a definitive agreement for $800,000 to provide IPO advisory services to Massimo Motor Sports, which manufactures all-terrain vehicles and utility task vehicles in Garland, Texas.

08:04 EDT VMware announces next evolution of VMware Partner Connect - VMware announced the next evolution of VMware Partner Connect - the company's singular, unified, global partner program. Partner Connect's new framework aligns to today's cloud, services, and solutions-centric business models, and will help partners drive better business performance and profitability today while transforming their businesses for tomorrow. "VMware has applied learnings from thousands of partners to drive the next evolution of Partner Connect and help partners perform while they transform. VMware is well positioned to help partners capture on the massive and growing opportunity in multi-cloud," said Tracy-Ann Palmer, vice president, Partner Experience, Programs and Investments, VMware. "We now have one unified partner program that will be more flexible and efficient, with simpler paths to progression and more tools to help manage partners' VMware business."

08:01 EDT BIO-key to showcase authentication methods at Gartner IAM Summit - BIO-key International will showcase new innovations at the Gartner Identity and Access Management Summit at Caesars Palace in Las Vegas, Nevada, August 22-24th. BIO-key will highlight new authentication methods, as additions to the current PalmPositive palm scanning method, for its BIO-key MobileAuth mobile app, including FacePositive for server-secured facial recognition, device-based biometrics for Android and iOS, and new push token support. They will also highlight a new admin user experience for its award-winning PortalGuard Identity-as-a-Service platform.

07:53 EDT Small Pharma announces TSXV approval of normal course issuer bid - Small Pharma announces that the TSX Venture Exchange has accepted the Company's application for its normal course issuer bid for up to five million common shares in the capital of the Company, representing 1.55% of the issued and outstanding Shares, over a 12-month period. The NCIB is expected to commence on August 19, 2022 and continue until August 18, 2023 or earlier in the event that the Company has acquired the maximum number of Shares that it may purchase under the NCIB or if the Company determines that it is appropriate to terminate the NCIB prior to the Termination Date. The actual number of Shares that will be purchased under the NCIB, if any, and the timing of such purchases will be determined by the Company from time to time. All purchases made pursuant to the NCIB will be made through the facilities of the TSXV in open market transactions or by such other means as may be permitted under applicable securities laws and the policies of the TSXV. All Shares purchased under the NCIB will be cancelled. The Company has engaged Eight Capital as the broker through which the Company will conduct purchases under the NCIB pursuant to the policies of the TSXV. The price that the Company will pay for the Shares purchased under the NCIB, if any, will be the market price of such Shares at the time of the applicable purchases. To the knowledge of the Company, no director, senior officer or other insider of the Company currently intends to sell any Shares under the NCIB.

07:41 EDT OverActive Media to host Canadian Overwatch League tournament - OverActive Media will host Canada's first-ever Overwatch League tournament from September 8 to September 11 at the Mattamy Athletic Centre in Toronto. This high-profile best-on-best esports tournament will see the top Overwatch players in the world compete for a $225,000 USD prize pool. The Toronto Defiant Summer Showdown Tournament powered by Bell will bring together esports, gaming, sports and entertainment fans to experience an action-packed four-day event, solidifying the city's position as a global esports hub. The tournament takes place ahead of the highly anticipated Overwatch 2 game launch which features a Toronto map, New Queen Street. The map is a tribute to the city and a patriotic moment for the Canadian Overwatch community as it includes notable landmarks like the CN Tower, City Hall, the Gooderham Building and the iconic Toronto sign.

07:38 EDT Alnylam to present data from the APOLLO-B Phase 3 study of patisiran - Alnylam Pharmaceuticals announced that the Company will present data from the APOLLO-B Phase 3 study of patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated, ATTR, amyloidosis with cardiomyopathy, during a late-breaker session at the 18th International Symposium on Amyloidosis on September 8, 2022. The Company announced positive topline results from the APOLLO-B study earlier this month. In addition, results from the Global Open-Label Extension study of patisiran, an RNAi therapeutic approved for the treatment of the polyneuropathy of hereditary ATTR amyloidosis in adults, will be presented at ISA, as well as results from a multicenter observational study evaluating the effectiveness of patisiran in patients with the polyneuropathy of hATTR amyloidosis with a V122I or T60A variant.

07:36 EDT Kohl's drops 8% to $31.25 after FY22 EPS guidance misses estimates - The company also cut its FY22 revenue growth outlook.

07:33 EDT Jazz Pharmaceuticals initiates Phase 3 trial of Epidiolex - Jazz Pharmaceuticals has initiated a new Phase 3 trial to investigate the efficacy and safety of Epidiolex - cannabidiol -, known as Epidyolex in Europe, in children and adolescents with Epilepsy with Myoclonic-Atonic Seizures, or EMAS. The study will investigate EMAS-associated seizure frequency over the 14-week treatment period compared to baseline. The company's cannabidiol is not currently approved in the U.S. or EU for the treatment of EMAS. EMAS is a developmental and epileptic encephalopathy that begins in early childhood. EMAS accounts for between one and two percent of all childhood-onset epilepsies.Seizures in children with EMAS are often difficult to treat and may not respond well to medication. The Phase 3 trial was initiated based on preliminary data from the company's clinical development program, including real-world evidence, that supports cannabidiol as an effective therapy for the treatment of myoclonic-atonic-associated seizures.

07:26 EDT Parsons joins United Nations Global Compact Initiative - Parsons Corporation announced that the company joined the United Nations Global Compact Initiative - a voluntary leadership platform for the development, implementation, and disclosure of responsible business practices that improves global sustainability. Launched in 2000, the UN Global Compact is the largest corporate sustainability initiative in the world, with more than 15,000 companies and 3,800 non-business signatories based in over 160 countries, and more than 69 local networks.

07:22 EDT Vox provides gold royalty developments, exploration updates - Vox Royalty provides recent development and exploration updates from royalty operating partners Norton Gold Fields, Northern Star Resources Limited (NESRF), Black Cat Syndicate, Norwest Minerals, and Tartisan Nickel. Kyle Floyd, Chief Executive Officer stated: "The past two months have seen material progress on certain Vox gold royalty assets, with the opening of the Binduli North gold mine, ongoing construction at the Otto Bore gold mine by Northern Star and meaningful pre-production planning at the Bulong and Bulgera gold toll-treatment projects. This progress continues to support Vox management expectations of organic growth from 6 to 10 or more producing royalties by late 2023 and further revenue growth." Key Updates: Official opening of the Binduli North heap leach mine covered by the Janet Ivy gold royalty, released by Zijin Mining Group (ZIJMY) subsidiary, Norton Gold; Construction update for the Otto Bore gold mine by Northern Star; Final high grade drilling results at the Myhree gold deposit by Black Cat, which is covered by the Bulong royalty; Development of pit designs, completion of a potential site layout and preparations for Mining Lease application at the Bulgera gold deposit by Norwest; and Completion of a Preliminary Economic Assessment and permitting update on the Kenbridge nickel project by Tartisan, indicating a potential 9-year mine life with a goal of production in approximately 3 years.

07:17 EDT Gamesquare Esports' Fourth Frame to be represented by UTA - GameSquare Esports announced that Fourth Frame Studios, a GameSquare Esports company, will be represented by United Talent Agency. Led by Damon Lau, Head of UTA's Gaming & Esports department, the team intends to introduce leading brands to Fourth Frame Studios' talented content production capabilities and its focus on youth culture and gaming content which is bridging the gap to make content more accessible and inclusive.

07:15 EDT Kinaxis selected by Confluent Medical for supply chain planning - Kinaxis announced that Confluent Medical Technologies has selected Kinaxis to digitize and introduce advanced supply chain planning capability for greater agility to demand changes, planning accuracy and inventory management. With Kinaxis, Confluent will have complete transparency of its supply chain, the ability to run multiple simulations and collaborate in real-time and leverage a full suite of applications to give the agility and flexibility needed to react to market volatility and changes in demand. Confluent joins a growing life sciences network within Kinaxis. "Getting the right products into the hands of patients when they need them and keeping up with regulations, life sciences supply chains are about as complex as they come," said John Sicard, Kinaxis CEO. "That makes end-to-end coordination and orchestration vital. We are excited to work with Confluent to help them reach all of their supply chain goals."

07:11 EDT El Pollo Loco adds to value selection menu - El Pollo Loco is doubling down on value with deals including an expanded $5 Fire-Grilled Combo menu, with the rollout of the new Shredded Chicken Quesadilla Combo, and Family Feast offerings starting at $24.

07:08 EDT OTC Markets Group welcomes Base Carbon to OTCQX - OTC Markets Group announced Base Carbon has qualified to trade on the OTCQX(R) Best Market. Base Carbon Inc. upgraded to OTCQX from the Pink market. Base Carbon Inc. begins trading on OTCQX under the symbol "BCBNF.

07:04 EDT BioCryst announces approval of ORLADEYO in Saudi Arabia - BioCryst Pharmaceuticals, announced that the Saudi Food and Drug Authority,SFDFA, has approved oral, once-daily ORLADEYO or berotralstat to prevent attacks of hereditary angioedema HAE in adults and pediatric patients 12 years of age and older in Saudi Arabia. "There is a significant need for new treatment options for HAE in Saudi Arabia. With this approval, we continue to deliver on our commitment to bringing our oral, once-daily prophylactic therapy to as many HAE patients around the world as possible," said Charlie Gayer, chief commercial officer of BioCryst. "This marks the second market in the MENA region in which ORLADEYO has been approved for patients living with HAE, building on the approval in the UAE last year. We are pleased with the decision from the Saudi FDA and we are committed to continuing our work with BioCryst to bring this important therapy to patients in the GCC who are in search of a more optimal treatment option to help manage their HAE," said Joe Henein, president and chief executive officer of NewBridge Pharmaceuticals. ORLADEYO was safe and well tolerated in clinical trials. The most frequently reported adverse reactions in patients receiving ORLADEYO compared with placebo were back pain and gastrointestinal reactions. The gastrointestinal reactions generally occurred early after initiation of treatment with ORLADEYO, became less frequent with time and typically self-resolved.

07:02 EDT Pixelworks makes strategic investment in Shanghai subsidiary - Pixelworks entered into an Equity Transfer Agreement with a group of private equity investors based in China for a portion of the company's equity interest in its majority owned subsidiary, Pixelworks Semiconductor Technology Shanghai, or PWSH. Collectively, the Purchasers have agreed to pay amounts in RMB equivalent to approximately $12.9M in exchange for a minority equity interest of 2.73% in PWSH. The purchase price values PWSH at RMB 3.2 billion or approximately $471.5M. Following the closing of the transaction, which is expected in September of 2022, Pixelworks will continue to hold an 80.87% equity interest in its PWSH subsidiary.

06:57 EDT Brookfield Business Partners renewing normal course issuer bid - Brookfield has received approval from the TSX for the renewal of its normal course issuer bid to purchase up to 10% of the public float of each series of the company's outstanding Class A Preference Shares that are listed on the TSX. The period of the normal course issuer bid will extend from August 22, 2022 to August 21, 2023, or an earlier date should Brookfield complete its purchases. All Preferred Shares acquired by Brookfield under this bid will be cancelled. Brookfield will enter into an automatic share purchase plan on or about the week of September 19, 2022 in relation to the normal course issuer bid.

06:50 EDT Estee Lauder says Shanghai distribution facilities returned to normal capacity - The company states: "The COVID-19 pandemic continued to disrupt the Company's operating environment globally, primarily impacting supply chain, inventory levels and other logistics during the year ended June 30, 2022. The resurgence of COVID-19 cases in many Chinese provinces led to restrictions late in the fiscal 2022 third quarter that remained in place through the end of fiscal 2022 to prevent further spread of the virus. Consequently, retail traffic, travel and distribution capabilities were temporarily curtailed. The Company's distribution facilities in Shanghai operated with limited capacity to fulfill brick-and-mortar and online orders beginning in mid-March 2022 and returned to normal capacity by early June 2022."

06:47 EDT BJ's Wholesale expects 11 new club openings in 2022 - Expansion plans remain on track with 11 new club openings expected in fiscal year 2022.

06:33 EDT Continental Resources appoints Doug Lawler as president - Continental Resources announced Doug Lawler is being promoted to President and COO. Doug joined Continental in February as COO and EVP following three decades in the oil and gas industry.

06:31 EDT Henry Schein raises share repurchase plan by $400M - Henry Schein announced that its Board of Directors has authorized the repurchase of up to $400M of shares of the company's common stock. This program is in addition to the $400M repurchase program announced in May 2021, which was fully executed. The company had approximately 136M shares outstanding as of August 17. This new authorization represents approximately 3.9% of shares outstanding at the current stock price.

06:11 EDT GenScript USA announces availability of monkeypox virus PCR test kit - GenScript USA announced the immediate availability of a monkeypox virus PCR test kit. The kit, which was developed in partnership with Anbio Biotechnology, can be ordered by diagnostic labs and medical device distributors to be used in research to provide detection of the monkeypox virus. The test kit has already received the CE mark for IVD use in the European Union.

06:09 EDT High Tide secures commitment letter from Connect First Credit Union - High Tide has entered into a binding commitment letter with Connect First Credit Union for a $19 million credit facility with an initial 5-year term at connectFirst's floor interest rate. The terms of the Credit Facility were renegotiated with connectFirst to provide a larger immediately-accessible facility for High Tide, with a smaller total commitment from connectFirst initially - which High Tide expects will grow over time. Upon closing the Credit Facility with connectFirst, the Company expects to use the proceeds to fund continued organic growth, general working capital requirements, and potential future M&A activities. The Company expects to close on the Credit Facility during the first half of September 2022, subject to certain pre-disbursement conditions and satisfaction of other customary conditions precedent.

06:05 EDT Terran Orbital delivers LunIR satellite to Cape Canaveral for Artemis 1 launch - Terran Orbital (LLAP) has delivered LunIR to Complex 39B at NASA's Kennedy Space Center. LunIR is a 6U satellite that will fly by the Moon and collect surface thermography as a secondary payload on Artemis 1 - a test mission for NASA's Space Launch System. SLS houses the Orion capsule - NASA's spacecraft that will take humans deep into space. After the flyby, LunIR will conduct technology demonstrations related to deep-space operations. The Lunar InfraRed imaging spacecraft, also known as LunIR, is the result of a joint effort between Lockheed Martin (LMT) and Terran Orbital. Lockheed Martin developed LunIR's infrared sensor and cryocooler. The company also provides the overall systems engineering and mission planning. Terran Orbital designed and built the spacecraft and is responsible for integration and mission assurance. The LunIR sensor could be an important tool for astronauts returning to the Moon, and going beyond to Mars.

06:03 EDT Eros Media World receives NYSE delisting notice, plans to appeal - Eros Media World announced that on August 17, it received a notice from the New York Stock Exchange that the staff of NYSE Regulation has determined to commence proceedings to delist the company's A ordinary shares and suspend trading immediately. The Staff Determination was issued because the company had not filed its annual report on Form 20-F for the year ended March 31, 2021, and semi-annual report on Form 6-K for the six months ended September 30, 2021 with the SEC, on or before August 17, 2022, which was the latest deadline allowed under Section 802.01E of the NYSE's Listed Company Manual. The company also did not file its annual report on Form 20-F for the period ended March 31, 2022 prior to the August 17, 2022 deadline. The Staff Determination does not impact the company's obligation to file periodic reports and other reports with the SEC under applicable U.S. securities laws. The company intends to request a review of the Staff Determination by a committee of the Board of Directors of the NYSE in accordance with Section 804.00 of the NYSE's Listed Company Manual. The review will be scheduled for a date that is at least 25 business days from the date the company requests such a review. As previously announced, on April 22, 2022, the company completed the sale of its STX Entertainment business to an affiliate of The Najafi Companies. Although the sale of the STX Entertainment business was necessary to enable the company to pursue its long term strategy and maximize long term value for shareholders, the separation of the two companies caused complex financial reporting and other transition issues. The company has been diligently working to address these issues and become current in its SEC reporting since the date of the sale.